Educational research content only. Not medical advice, diagnosis, or treatment. Nothing on this site is intended to promote human use, self-administration, or the substitution of professional healthcare.

← Peptide Library
SKIN & REGENERATIONSN8

SNAP-8

An elongated acetyl octapeptide analog of Argireline studied topically for modulation of SNARE-complex assembly and expression-line research in dermal models.

Half-Life
Short
Onset
Gradual
Symbol
SN8
Category
Skin

⏱ Half-Life

Short duration profile

SNAP-8 demonstrates a short half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.

⚡ Onset Characteristics

Gradual measurable response

Onset is observed as gradual — a property that influences how researchers structure comparative studies versus other compounds in the skin & regeneration category.

🧠 Key Notes

What makes it distinct

  • 01Acetyl octapeptide-3 — extended analog of Argireline (acetyl hexapeptide-8)
  • 02Topical-only research use in dermal models
  • 03Studied at 5–10% concentrations in cosmetic literature

🧬 Mechanism of Action

How it works

SNAP-8 (acetyl octapeptide-3) is an elongated derivative of Argireline that mimics the N-terminal end of the SNAP-25 protein — a core component of the SNARE complex required for pre-synaptic vesicle docking and neurotransmitter release at the neuromuscular junction. By competing with native SNAP-25 for SNARE-complex assembly, SNAP-8 modulates acetylcholine release at cutaneous motor endplates, reducing repetitive micro-contractions associated with dynamic expression lines. Its two additional amino acids relative to Argireline are reported to improve topical potency and dermal-layer penetration in cosmetic research.

✨ Documented Benefits

What the research shows it supports

B01Reduces depth of dynamic expression lines in dermal research models at 5–10% topical concentrations.
B02Improved potency vs Argireline in comparative topical studies.
B03Well-tolerated topical safety profile in published cosmetic literature.
B04Non-invasive alternative research tool to injectable neuromodulator studies.

🔍 Research Insights

What the literature shows

INSIGHT 01

Extended sequence relative to Argireline is reported to enhance SNARE-complex competition potency.

INSIGHT 02

Effects are cumulative and become apparent across weeks of repeated topical research application.

INSIGHT 03

Systemic absorption from intact-skin topical use is negligible in published pharmacokinetic data.

🧪 Typical Research Use Cases

Where it appears in study design

USE CASE 01

Comparative topical dermal research vs Argireline and Matrixyl.

USE CASE 02

Expression-line and dermal-signalling studies.

USE CASE 03

SNARE-complex modulation research in cutaneous models.

📚 References

Peer-reviewed literature

Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.

  1. [01]

    Blanes-Mira, C. et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science, 24(5), 303–310.

    International Journal of Cosmetic Science
  2. [02]

    Wang, Y. et al. (2013). The anti-wrinkle efficacy of Argireline, a synthetic hexapeptide, in Chinese subjects. American Journal of Clinical Dermatology, 14(2), 147–153.

    American Journal of Clinical Dermatology
  3. [03]

    Lim, S. H. et al. (2018). Cosmeceuticals for the anti-aging of skin. Cosmetics, 5(1), 16.

    Cosmetics
  4. [04]

    Errante, F. et al. (2020). Cosmeceutical peptides in the framework of sustainable wellness. Frontiers in Chemistry, 8, 572923.

    Frontiers in Chemistry

⚠️ Not Medical Advice

Educational research summary only

This profile summarises published research on SNAP-8. It is not medical advice, diagnosis, or treatment, and it is not intended to promote human use, self-administration, or the substitution of professional healthcare. Discuss any health decision with a licensed clinician.

Continue Exploring

Also explore: GHK-Cu, BPC-157, TB-500